Trade ADMA Biologics, Inc. - ADMA CFD
Add to favourite- Summary
- Historical Data
Spread | 0.1064 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 16.0168 |
Open | 15.6468 |
1-Year Change | 209.27% |
Day's Range | 15.6468 - 16.3568 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jan 24, 2025 | 16.0168 | -0.3600 | -2.20% | 16.3768 | 16.4868 | 16.0168 |
Jan 23, 2025 | 16.5268 | 0.2200 | 1.35% | 16.3068 | 16.5268 | 15.8668 |
Jan 22, 2025 | 16.4268 | 0.3000 | 1.86% | 16.1268 | 16.4268 | 15.8968 |
Jan 21, 2025 | 16.1268 | 0.0700 | 0.44% | 16.0568 | 16.3968 | 15.8768 |
Jan 17, 2025 | 15.9668 | -0.7600 | -4.54% | 16.7268 | 16.7268 | 15.9368 |
Jan 16, 2025 | 16.5768 | 0.0200 | 0.12% | 16.5568 | 16.9468 | 16.3568 |
Jan 15, 2025 | 16.6568 | -0.1700 | -1.01% | 16.8268 | 17.1268 | 16.4368 |
Jan 14, 2025 | 16.2668 | -0.3500 | -2.11% | 16.6168 | 16.6268 | 15.8768 |
Jan 13, 2025 | 16.4268 | -1.5000 | -8.37% | 17.9268 | 18.0568 | 16.4268 |
Jan 10, 2025 | 18.5068 | 0.4700 | 2.61% | 18.0368 | 18.7568 | 17.8868 |
Jan 8, 2025 | 18.5168 | 0.4100 | 2.26% | 18.1068 | 18.5268 | 17.8868 |
Jan 7, 2025 | 18.2668 | -0.8700 | -4.55% | 19.1368 | 19.1368 | 17.7568 |
Jan 6, 2025 | 19.0868 | 0.4400 | 2.36% | 18.6468 | 19.1468 | 18.4868 |
Jan 3, 2025 | 18.3668 | 0.4100 | 2.28% | 17.9568 | 18.4368 | 17.8668 |
Jan 2, 2025 | 17.9268 | 0.6600 | 3.82% | 17.2668 | 18.0768 | 17.0568 |
Dec 31, 2024 | 17.0968 | -0.4700 | -2.68% | 17.5668 | 17.6268 | 16.9168 |
Dec 30, 2024 | 17.4368 | 0.3200 | 1.87% | 17.1168 | 17.4768 | 16.9068 |
Dec 27, 2024 | 17.4068 | -0.2000 | -1.14% | 17.6068 | 17.6668 | 17.0168 |
Dec 26, 2024 | 17.8368 | 0.6800 | 3.96% | 17.1568 | 17.8468 | 17.1568 |
Dec 24, 2024 | 17.3268 | -0.3600 | -2.04% | 17.6868 | 17.6868 | 17.2368 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
ADMA Biologics, Inc. Company profile
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.Industry: | Biopharmaceuticals |
C/O Adma Biologics, Inc.
465 State Route 17
RAMSEY
NEW JERSEY 07446
US
News
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com